Opticare Ointment
Indicated to address tear production deficits to manage dry eye disease and alleviate local corneal discomfort.
- Category
- Eye Care
- Active ingredient
- Ciclosporin
- Route
- Ocular use
- Form
- Ophthalmic Ointment
- Strengths
- 2mg
Prescription and consultation requirements for Opticare Ointment vary by destination and are determined by the fulfilment partner.
Opticare Ointment details
- Conditions
- Keratoconjunctivitis Sicca · Dry Eye Disease
- Alternative names
- cyclosporine
- Therapeutic class
- Calcineurin Inhibitor
- Pharmacological class
- Ophthalmic Immunosuppressant
- Contraindications
- active ocular infection; hypersensitivity to cyclosporine
- Minor side effects
- ocular burning; stinging; eye redness
- Moderate side effects
- lacrimation; eye discharge; blurred vision
- Serious side effects
- severe ocular hypersensitivity, requires immediate medical attention
- Dosage forms
- Ophthalmic Ointment
- Administration route
- Ocular use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla
- Onset Time
- 4–8 weeks
- Duration
- 12 hours
- Storage instructions
- Store below 25°C. Do not freeze.
- Age restrictions
- Approved for children over sixteen years and adults.
Patient summary
indicated to address tear production deficits to manage dry eye disease and alleviate local corneal discomfort.
Mechanism of action
Acts locally as an immunomodulator, blocking inflammatory cytokines to restore normal lacrimal gland tear output.
Pregnancy and breastfeeding
TGA Category C: Minimal systemic absorption. Use caution. Breastfeeding: Compatible.